Loading news...
HOUSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Natural Resource Partners L.P. (NYSE: NRP) announced today that it filed the partnership's Annual Report Form 10-K for the period ended December 31, 2025 with the Securities and Exchange Commission on February 27, 2026.
IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C.
Navios Maritime Partners (NMM) remains a compelling buy, with robust Q4 results, ongoing buybacks, and a diversified fleet strategy underpinning long-term value. NMM's capital allocation prioritizes deleveraging, selective fleet renewal, and steady buybacks, with a net LTV target of 20–25% and current NAV at $140.3 per share. Despite a 40% YTD stock increase, NMM trades at just 0.5x NAV, with a fair value estimate raised to $100 per share, implying 40% upside.
Partnership aims to expand real-world access for USDPT and support Western Union's new Digital Asset Network NEW YORK, March 4, 2026 /PRNewswire/ -- Crossmint , a leading platform for enterprise-grade stablecoin infrastructure, today announced that it is partnering with Western Union (NYSE: WU) to support the rollout of USDPT , Western Union's new U.S. dollar-denominated stablecoin that will be issued on Solana , and the company's newly announced Digital Asset Network. Western Union's Digital Asset Network is designed to link stablecoins to real-world cash access, allowing users to convert digital dollars into local currency through more than 360,000 collection points worldwide.
ANKENY, Iowa--(BUSINESS WIRE)--Casey's, the third‑largest convenience retailer and fifth‑largest pizza chain in the U.S., today launches its annual giving campaign to help end hunger across Casey's Country. In partnership with Feeding America and DoorDash, Casey's is committed to helping provide 10 million meals* to local Feeding America partner food banks in its communities. Through April 7, Casey's guests can join the movement to end hunger by: Rounding up in-store purchases Adding a donation.
DAYTON, Ohio--(BUSINESS WIRE)-- #highered--The University of Dayton School of Law is providing its students with comprehensive bar exam preparation through a new partnership with Kaplan.
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Surgery Partners, Inc. (NASDAQ: SGRY). The investigation focuses on Surgery Partners' executive officers and whether investor losses may be recovered under federal securities laws.
NEW YORK--(BUSINESS WIRE)--SharonAI Holdings Inc. and its subsidiaries (“Sharon AI”), a leading Australian Neocloud (NASDAQ:SHAZ), today announced it has partnered with World Wide Technology (“WWT”) for the deployment of large-scale high-performance compute infrastructure in Australia and Asia-Pacific. Leveraging more than three decades of global experience delivering complex, mission-critical infrastructure, WWT brings deep capability across AI Factory engineering, global procurement and suppl.
Surgery Partners saw shares drop 14.1% after Q4 2025 results, with revenue beating estimates but profitability disappointing. SGRY expanded surgical facilities and increased revenue per case, but total case volume fell due to asset sales, impacting short-term results. Despite mixed profitability, SGRY trades at attractive EV/EBITDA and operating cash flow multiples versus peers, supporting a soft ‘buy' upgrade.
Coca-Cola Europacific Partners remains a Hold as Q4 results showed improvement, but valuation is now stretched at ~21x forward PE. Europe exited Q4 better than feared, with targeted pricing and promotions aiding Germany, yet volume growth remains weak and demand pressure persists. Energy and away-from-home channels continue to drive growth, while APS headwinds are easing, particularly with portfolio normalization in Indonesia and the Philippines.
CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST.
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in a fireside chat and host investor meetings at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026 in Miami, Florida.
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that management is scheduled to present at the 2026 Leerink Partners Global Healthcare Conference on Wednesday, March 11th at 2:20 p.m. ET. An audio webcast of the fireside chat can be accessed on the Investors sectio.
SOUTH SAN FRANCISCO, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Timothy Lu, M.D.
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026 at 8:00 a.m. ET.
CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that company management will present at the Leerink Partners Global Healthcare Conference in Miami, FL on Tuesday, March 10, 2025 at 1:00 p.m.
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication. Phase 1 clinical trial of the patent-pending, rapid-onset formulation planned for mid-2026.
CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P.
ALBUQUERQUE, N.M.--(BUSINESS WIRE)---- $AVAV #AVAV--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a global leader in advanced defense and aerospace solutions, today announced plans to invest more than $30 million to significantly expand its manufacturing operations in Albuquerque, New Mexico. Supported by an initial $5 million from the State of New Mexico and $1 million from the City of Albuquerque through the Local Economic Development Act (LEDA), the investment will expand AV's manufacturing operations across i.
CHAPEL HILL, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, announced today that the Company will participate in a fireside chat at the 2026 Leerink Partners Global Healthcare Conference, which is taking place from March 8-11, 2026, in Miami, FL.